These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25041427)

  • 1. Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacs.
    Mohammed BM; Martin EJ; Salinas V; Carmona R; Young G; Brophy DF
    J Thromb Haemost; 2014 Sep; 12(9):1558-61. PubMed ID: 25041427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.
    van Veen JJ; Gatt A; Cooper PC; Kitchen S; Bowyer AE; Makris M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):183-9. PubMed ID: 18388496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors?
    Salinas V; Carmona R; Mohammed BM; Martin EJ; Brophy DF; Young G
    Haemophilia; 2015 May; 21(3):398-404. PubMed ID: 25495850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of corn trypsin inhibitor on the contribution of coagulation determinants to the Technoclone Thrombin Generation Assay (TGA) and the Calibrated Automated Thrombogram (CAT).
    Touw CE; de Jong Y; van Hylckama Vlieg A
    PLoS One; 2022; 17(2):e0263960. PubMed ID: 35213588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood.
    Hansson KM; Nielsen S; Elg M; Deinum J
    J Thromb Haemost; 2014 Oct; 12(10):1678-86. PubMed ID: 25142753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition.
    Luddington R; Baglin T
    J Thromb Haemost; 2004 Nov; 2(11):1954-9. PubMed ID: 15550027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?
    Spronk HM; Dielis AW; Panova-Noeva M; van Oerle R; Govers-Riemslag JW; Hamulyák K; Falanga A; Cate HT
    Thromb Haemost; 2009 Jun; 101(6):1156-62. PubMed ID: 19492161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe haemophiliacs: comment.
    Tripodi A; Chantarangkul V; Santagostino E
    J Thromb Haemost; 2015 Jan; 13(1):163-4. PubMed ID: 25354335
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa.
    van de Berg TW; Beckers EAM; Heubel-Moenen FCJI; Henskens YMC; Thomassen MCLGD; Hackeng TM
    Thromb Haemost; 2023 Nov; 123(11):1034-1041. PubMed ID: 37236229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
    Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
    Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
    Ogiwara K; Nogami K; Matsumoto N; Noguchi-Sasaki M; Hirata M; Soeda T; Shima M
    Int J Hematol; 2020 Nov; 112(5):621-630. PubMed ID: 32748217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition.
    Li R; Panckeri KA; Fogarty PF; Diamond SL
    Haemophilia; 2015 Mar; 21(2):266-274. PubMed ID: 25311576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.
    Waters EK; Hilden I; Sørensen BB; Ezban M; Holm PK
    J Thromb Haemost; 2015 Nov; 13(11):2041-52. PubMed ID: 26340413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation in hemophilia A and hemophilia C.
    Cawthern KM; van 't Veer C; Lock JB; DiLorenzo ME; Branda RF; Mann KG
    Blood; 1998 Jun; 91(12):4581-92. PubMed ID: 9616154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors.
    Bravo MI; Da Rocha-Souto B; Grancha S; Jorquera JI
    Haemophilia; 2014 Nov; 20(6):905-11. PubMed ID: 25156825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the thrombin generation profiles of four different rFVIII products in FVIII-deficient plasma using FIXa and FXIa activation.
    Brophy DF; Martin EJ; Ninivaggi M; Mohammed BM; Barrett JC; Kuhn J; Nolte ME; Waters EK; Ezban M
    Haemophilia; 2018 Sep; 24(5):815-822. PubMed ID: 30112856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists.
    de Koning MLY; Fischer K; de Laat B; Huisman A; Ninivaggi M; Schutgens REG
    J Thromb Haemost; 2017 May; 15(5):868-875. PubMed ID: 28296129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
    Pike GN; Cumming AM; Hay CR; Bolton-Maggs PH; Burthem J
    Blood; 2015 Jul; 126(3):397-405. PubMed ID: 25911238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A.
    Mancuso ME; Chantarangkul V; Clerici M; Fasulo MR; Padovan L; Scalambrino E; Peyvandi F; Tripodi A; Santagostino E
    Haemophilia; 2016 Jul; 22(4):e286-91. PubMed ID: 27166132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.